Cosmos Health (NASDAQ:COSM) CEO Purchases $38,134.40 in Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas purchased 56,080 shares of Cosmos Health stock in a transaction on Friday, November 21st. The shares were acquired at an average cost of $0.68 per share, with a total value of $38,134.40. Following the completion of the transaction, the chief executive officer directly owned 6,327,893 shares in the company, valued at $4,302,967.24. The trade was a 0.89% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Grigorios Siokas also recently made the following trade(s):

• On Thursday, November 20th, Grigorios Siokas acquired 51,315 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.62 per share, for a total transaction of $31,815.30.
• On Wednesday, November 19th, Grigorios Siokas acquired 61,614 shares of Cosmos Health stock. The stock was acquired at an average price of $0.65 per share, for a total transaction of $40,049.10.

Cosmos Health Stock Performance

Shares of Cosmos Health stock traded up $0.03 during trading on Monday, hitting $0.71. 125,550 shares of the company’s stock were exchanged, compared to its average volume of 611,185. The stock has a market capitalization of $24.69 million, a price-to-earnings ratio of -0.94 and a beta of 5.32. The business has a 50-day simple moving average of $0.93 and a 200-day simple moving average of $0.71. Cosmos Health Inc. has a 52-week low of $0.28 and a 52-week high of $1.32. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.84 and a current ratio of 0.99.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings results on Friday, November 14th. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.16). The company had revenue of $17.11 million for the quarter, compared to analyst estimates of $16.40 million. Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%. On average, research analysts forecast that Cosmos Health Inc. will post -0.78 EPS for the current year.

Analyst Ratings Changes

Several analysts recently commented on COSM shares. Wall Street Zen raised Cosmos Health to a “hold” rating in a report on Saturday, September 20th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cosmos Health in a research note on Wednesday, October 8th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

Hedge Funds Weigh In On Cosmos Health

A hedge fund recently raised its stake in Cosmos Health stock. Citadel Advisors LLC boosted its holdings in shares of Cosmos Health Inc. (NASDAQ:COSM) by 133.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 225,507 shares of the company’s stock after purchasing an additional 128,776 shares during the quarter. Citadel Advisors LLC owned approximately 0.65% of Cosmos Health worth $250,000 at the end of the most recent reporting period. Institutional investors own 12.61% of the company’s stock.

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.